A Study to Evaluate RMC-035 in Subjects Undergoing Cardiac Surgery
Status:
Completed
Trial end date:
2021-07-15
Target enrollment:
Participant gender:
Summary
The purpose of the clinical study is to assess safety, tolerability and pharmacokinetics of
RMC-035 for the prevention and treatment of acute kidney injury (AKI) in patients undergoing
cardiac surgery.